Plain-English translation of NCT06946550 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a 1470 nm non-ablative laser called the Sciton HALO to treat scarring alopecia, a condition where hair follicles are permanently damaged, causing hair loss. The laser creates tiny controlled channels in the skin to potentially help hair regrow. Researchers will also study how the treatment affects your hair follicles at the cellular level to understand why it might work.
Scarring alopecia is difficult to treat, and current options are limited. This trial aims to see if the laser can reduce scarring and potentially restore hair growth while understanding the biological mechanisms behind how this treatment works.
You likely qualify if…
You likely don't qualify if…
You will receive three 10-to-15-minute laser treatments spaced one month apart. Before and after each treatment, the area will be cleaned and numbed with topical anesthetic. You'll return for follow-up visits at months 4, 6, 9, 12, and 15 to monitor your progress. The researchers will also pluck a few hairs before your first treatment and one month after your last treatment to study how the laser affects your hair follicles at a cellular level.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States